June 25, 2024
Click lick below to watch the video: https://www.bitchute.com/video/FPlqPvmeDHG7/
June 18, 2024
“AMC Entertainment Holdings Inc. said Monday that its theaters just had their best weekend of the year in terms of moviegoers, but that didn’t stop the company’s shares from dropping in sympathy with those of fellow meme stock GameStop Corp.… Continue Reading…
May 21, 2024
“Sutro Biopharma (STRO)… “We think that luvelta has the potential to treat up to 80% of PROC patients, a significant improvement over the ~30% eligible for AbbVie’s Elahere (approved FolRα ADC)… Overall, the Strong Buy consensus rating on STRO is based… Continue Reading…
May 13, 2024
“Auna S.A. (AUNA)… Cepeda’s views back up his Overweight (Buy) rating on the stock, and his $14 price-target points toward a robust 110% upside potential for the next 12 months. (To watch Cepeda’s track record, click here)… Contineum Therapeutics (CTNM)… Hung goes… Continue Reading…
March 29, 2024
“Shares of Viking Therapeutics (NASDAQ: VKTX) are up about 275% in 2023, but analysts on Wall Street think it isn’t finished climbing yet. The consensus price target on the clinical-stage biotech stock suggests a 47% gain could be up ahead…. Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have more… Continue Reading…
March 28, 2024
“…SoFi stock: Down 26% this year and 73% from its high… SoFi’s revenue increased 35% year over year to $615 million in the fourth quarter, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) increased 159% to $181 million.… Continue Reading…
March 15, 2024
“…Next up is the online insurance marketplace EverQuote. This company operates a platform that connects insurance buyers with insurance agents and covers multiple aspects of the industry… As more and more consumers, across the economy generally, turn to online and… Continue Reading…
March 5, 2024
“…Adria Cimino (Intellia Therapeutics): Intellia stock has dropped more than 80% below its high over the past three years, even as this CRISPR gene-editing specialist moves closer to the finish line with its lead candidates. And this could offer bargain-hunting investors looking for… Continue Reading…
February 26, 2024
“Share prices of Nvidia (NASDAQ: NVDA) and CrowdStrike (NASDAQ: CRWD) soared more than 1,000% and 400%, respectively, over the last four years. Those monster gains make the companies stock-split candidates in 2024, but both are worthwhile investments whether or not those splits happen… Grand View Research… Continue Reading…
Recent Comments